mutation and glucose metabolism in thyroid cancer patients : An 18 F-FDG-PET study

[1]  Jason Li,et al.  Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. , 2014, Cancer discovery.

[2]  B. Cha,et al.  Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma. , 2013, Thyroid : official journal of the American Thyroid Association.

[3]  Bo Hyun Kim,et al.  Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma , 2013, Nuclear medicine communications.

[4]  P. Ladenson,et al.  Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. , 2013, JAMA.

[5]  H. Ryu,et al.  The value of preoperative PET–CT in papillary thyroid cancer , 2013, The Journal of international medical research.

[6]  A. Piccardo,et al.  Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. , 2012, The Journal of clinical endocrinology and metabolism.

[7]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[8]  A. Bockisch,et al.  Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma , 2012, Clinical nuclear medicine.

[9]  K. Schmid,et al.  The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression. , 2011, Thyroid : official journal of the American Thyroid Association.

[10]  R. Celestino,et al.  Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas , 2011, Current genomics.

[11]  M. Shah,et al.  Role of BRAF in Thyroid Oncogenesis , 2011, Clinical Cancer Research.

[12]  Chris Sander,et al.  18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. , 2011, Cancer research.

[13]  K. Kinzler,et al.  Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.

[14]  Mithat Gonen,et al.  Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  Y. Erdi,et al.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Z. Keidar,et al.  PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.